Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding
Gastroenterol Hepatol. 2018 Jan;41(1):63-76.
doi: 10.1016/j.gastrohep.2017.08.012.
Epub 2017 Oct 27.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Gastroenterología, Centro Médico Teknon, Barcelona, España.
- 2 Servicio de Enfermedades Digestivas, Hospital Universitario, Universidad de Zaragoza, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínico Universitario, Zaragoza, España.
- 3 Departamento de Gastroenterología, Hospital Donostia/Instituto Biodonostia; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD); Universidad del País Vasco (UPV/EHU), San Sebastián, España.
- 4 Servicio de Patología Digestiva, Consorcio Hospital General Universitario de Valencia, Valencia, España.
- 5 Departamento de Gastroenterología, Hospital da Senhora da Oliveira, Guimarães, Portugal; Instituto de Investigación en Ciencias de la Vida y la Salud (ICVS), Escuela de Ciencias de la Salud, Universidad de Minho, Portugal; ICVS/3B's, Laboratorio Asociado al Gobierno de Portugal, Braga/Guimarães, Portugal.
- 6 Servicio de Digestivo, Hospital Universitario Reina Sofía, Córdoba, España.
- 7 Servicio de Gastroenterología y Hepatología, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, España.
- 8 Departamento de Gastroenterología, Hospital General San Jorge, Huesca, España.
- 9 Servicio de Aparato Digestivo, Hospital Universitario de La Princesa e Instituto de Investigación Sanitaria Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España. Electronic address: [email protected].
Abstract
Despite high prevalence of iron deficiency anemia (IDA) in patients with acute or chronic gastrointestinal bleeding (GIB), IDA and iron deficiency (ID) are frequently untreated. Reasons may be misconceptions about the impact and diagnosis of IDA and the efficacy of new treatments. Addressing these misconceptions, this article summarizes current evidence for better understanding and management of GIB-associated IDA. Despite only few controlled studies evaluated the efficacy of iron treatment in patients with GIB, there is consistent evidence suggesting that: (a) IDA should be diligently investigated, (b) effective treatment of ID/IDA improves outcomes such as health-related quality of life and can avoid severe cardiovascular consequences, and (c) intravenous iron should be considered as well-tolerated treatment in this setting. Overall, the misconceptions and practices outlined in this article should be replaced with strategies that are more in line with current guidelines and best practice in GIB and other underlying conditions of ID/IDA.
Keywords:
Anemia; Diagnosis; Diagnóstico; Gastrointestinal bleeding; Hemorragia digestiva; Hierro; Iron; Tratamientos; Treatments.
Copyright © 2017 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Anemia, Iron-Deficiency / diagnosis
-
Anemia, Iron-Deficiency / drug therapy
-
Anemia, Iron-Deficiency / epidemiology
-
Anemia, Iron-Deficiency / etiology*
-
Cardiovascular Diseases / prevention & control
-
Delayed Diagnosis
-
Disease Management
-
Drug Monitoring / standards
-
Ferritins / blood
-
Gastrointestinal Hemorrhage / complications*
-
Gastrointestinal Hemorrhage / diagnosis
-
Gastrointestinal Hemorrhage / therapy
-
Hemoglobins / analysis
-
Hospitalization
-
Humans
-
Infusions, Intravenous
-
Iron / administration & dosage
-
Iron / therapeutic use
-
Iron Deficiencies
-
Practice Guidelines as Topic
-
Prevalence
-
Quality of Life
Substances
-
Hemoglobins
-
Ferritins
-
Iron